Form 4: Natera Executive Sells Shares for Tax Obligations
Insider Transaction Report
Natera's President of Clinical Diagnostics, Solomon Moshkevich, sold shares to cover tax obligations related to RSU vesting.
Summary
- Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NTRA), reported two sales of Natera Common Stock.
- On January 27, 2026, 1,013 shares were sold at a price of $240.5313 per share.
- On January 28, 2026, an additional 1,200 shares were sold at a price of $237.6624 per share.
- These sales were executed to satisfy tax withholding and remittance obligations associated with the vesting of Restricted Stock Units (RSUs).
- The transactions were conducted pursuant to a Rule 10b5-1(c) written instruction plan.
- Following these reported transactions, Solomon Moshkevich directly beneficially owns 142,486 shares of Natera Common Stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sales are routine, non-discretionary transactions for tax purposes, which do not reflect a change in the executive's investment thesis or the company's fundamentals.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Natera's future outlook.
Industry Context
StockSavvy.ai notes that routine sales of shares by executives to cover tax withholding obligations upon RSU vesting are common practice across industries and are typically non-discretionary events, often pre-arranged under Rule 10b5-1 plans. Such transactions are generally not indicative of management's sentiment regarding the company's future performance or a change in strategic direction.
Key Dates
| Date | Description |
|---|---|
| 01/27/2023 | Grant date of Stock Unit Agreement related to the sale of 1,200 shares. |
| 01/26/2024 | Grant date of Stock Unit Agreement related to the sale of 1,013 shares. |
| 01/27/2026 | Date of the first reported transaction (sale of 1,013 shares). |
| 01/28/2026 | Date of the second reported transaction (sale of 1,200 shares). |
| 01/29/2026 | Date the Form 4 was filed. |
Recommendation
holdThe reported transactions are routine, non-discretionary sales by an executive to cover tax obligations related to RSU vesting, executed under a pre-arranged 10b5-1 plan. This type of insider activity typically does not signal a change in the company's fundamental prospects or the executive's long-term view, thus it does not warrant a change in investment recommendation based solely on this filing.
Keywords
Natera, NTRA, Form 4, Insider Transaction, RSU, Stock Sale, Tax Withholding, Solomon Moshkevich, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.